Portola Pharmaceuticals reports fourth quarter and year-end 2014 financial results
Portola Pharmaceuticals reported the net loss for the 2014 year end was $137.1 million or $3.19 net loss per share, versus a net loss of $83.4 million, or $3.65 net loss per share, in 2013. Cash, cash equivalents and investments at December 31, 2014, totaled $392.3 million. March 02, 2015